These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11474745)

  • 21. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.
    Hambleton P
    J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the dissociation of botulinum neurotoxin type A complexes.
    Eisele KH; Fink K; Vey M; Taylor HV
    Toxicon; 2011 Mar; 57(4):555-65. PubMed ID: 21195107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mode of action and effects of botulinum neurotoxin A].
    Périé S; Lacau St-Guily J
    Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of botulinum toxins A and B in the treatment of facial rhytides.
    Sadick NS; Matarasso SL
    Dermatol Clin; 2004 Apr; 22(2):221-6. PubMed ID: 15222583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
    Wheeler A; Smith HS
    Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of acute and chronic botulinum toxin treatment on receptor number, receptor distribution and tissue sensitivity in rat diaphragm.
    Simpson LL
    J Pharmacol Exp Ther; 1977 Feb; 200(2):343-51. PubMed ID: 839441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous output of acetylcholine from rat diaphragm preparations declines after treatment with botulinum toxin.
    Gundersen CB; Jenden DJ
    J Pharmacol Exp Ther; 1983 Feb; 224(2):265-8. PubMed ID: 6822953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE
    Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum neurotoxin].
    Poulain B
    Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.
    Brin MF
    Muscle Nerve Suppl; 1997; 6():S146-68. PubMed ID: 9826987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin: a dreaded toxin for use in human being.
    Ghosh B; Das SK
    J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium botulinum toxins: nature and preparation for clinical use.
    Melling J; Hambleton P; Shone CC
    Eye (Lond); 1988; 2 ( Pt 1)():16-23. PubMed ID: 3410136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin for palatal myoclonus and spastic dysphonia].
    Greenberg E; Giladi N; Meer J; Uri N; Honigman S
    Harefuah; 1993 Dec; 125(11):402-4, 448. PubMed ID: 8112664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N; Kamata Y; Simpson LL
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commercial preparations and handling of botulinum toxin type A and type B.
    Parish JL
    Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.